Literature DB >> 23179659

The association between chronic renal failure and renal cell carcinoma may differ between black and white Americans.

Jonathan N Hofmann1, Kendra Schwartz, Wong-Ho Chow, Julie J Ruterbusch, Brian M Shuch, Sara Karami, Nathaniel Rothman, Sholom Wacholder, Barry I Graubard, Joanne S Colt, Mark P Purdue.   

Abstract

PURPOSE: In the United States, renal cell carcinoma (RCC) incidence is higher among blacks than among whites. Risk of RCC is elevated among end-stage renal disease patients, although no studies have looked at differences by race in the relationship between chronic renal failure and RCC.
METHODS: We investigated RCC risk in relation to chronic renal failure in a population-based case-control study of blacks and whites in Chicago and Detroit. Data, including information on kidney disease, were collected from interviews with 1,217 RCC cases (361 blacks, 856 whites) and 1,235 controls (523 blacks, 712 whites). Odds ratios (OR) and 95 % confidence intervals (CI) were estimated using unconditional logistic regression.
RESULTS: Risk of RCC was increased in relation to chronic renal failure (OR 4.7, 95 % CI 2.2-10.1) and dialysis (OR 18.0, 95 % CI 3.6-91). The association remained after defining exposure as those who had chronic renal failure ≥10 years prior to RCC diagnosis. Chronic renal failure was more strongly associated with RCC among blacks than among whites (OR 8.7, 95 % CI 3.3-22.9 and 2.0, 0.7-5.6, respectively; p (interaction) = 0.03) and among those without a history of diabetes relative to diabetic subjects (OR 8.3, 95 % CI 3.1-22.7 and 1.9, 0.6-5.9, respectively; p (interaction) = 0.03).
CONCLUSIONS: These results suggest that chronic renal failure is a strong risk factor for RCC, particularly among black and non-diabetic subjects. Our findings of differences in risk estimates by race, to our knowledge the first such report, require replication.

Entities:  

Mesh:

Year:  2012        PMID: 23179659      PMCID: PMC3531044          DOI: 10.1007/s10552-012-0102-z

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  22 in total

1.  Incidence and spectrum of dialysis-associated cancer in three continents.

Authors:  A Heidland; U Bahner; S Vamvakas
Journal:  Am J Kidney Dis       Date:  2000-02       Impact factor: 8.860

2.  Cancer incidence before and after kidney transplantation.

Authors:  Claire M Vajdic; Stephen P McDonald; Margaret R E McCredie; Marina T van Leeuwen; John H Stewart; Matthew Law; Jeremy R Chapman; Angela C Webster; John M Kaldor; Andrew E Grulich
Journal:  JAMA       Date:  2006-12-20       Impact factor: 56.272

Review 3.  Variance estimation for complex surveys using replication techniques.

Authors:  K F Rust; J N Rao
Journal:  Stat Methods Med Res       Date:  1996-09       Impact factor: 3.021

4.  Methylenetetrahydrofolate reductase (MTHFR) polymorphism A1298C (Glu429Ala) predicts decline in renal function over time in the African-American Study of Kidney Disease and Hypertension (AASK) Trial and Veterans Affairs Hypertension Cohort (VAHC).

Authors:  Maple M Fung; Rany M Salem; Michael S Lipkowitz; Vibha Bhatnagar; Braj Pandey; Nicholas J Schork; Daniel T O'Connor
Journal:  Nephrol Dial Transplant       Date:  2011-05-25       Impact factor: 5.992

5.  Rates of completion of the medical evaluation for renal transplantation.

Authors:  Francis L Weng; Marshall M Joffe; Harold I Feldman; Kevin C Mange
Journal:  Am J Kidney Dis       Date:  2005-10       Impact factor: 8.860

6.  Cancer in patients on dialysis for end-stage renal disease: an international collaborative study.

Authors:  P Maisonneuve; L Agodoa; R Gellert; J H Stewart; G Buccianti; A B Lowenfels; R A Wolfe; E Jones; A P Disney; D Briggs; M McCredie; P Boyle
Journal:  Lancet       Date:  1999-07-10       Impact factor: 79.321

7.  Prevalence of chronic kidney disease and associated risk factors--United States, 1999-2004.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2007-03-02       Impact factor: 17.586

8.  Racial differences in the incidence of hypertensive end-stage renal disease (ESRD) are not entirely explained by differences in the prevalence of hypertension.

Authors:  W McClellan; E Tuttle; A Issa
Journal:  Am J Kidney Dis       Date:  1988-10       Impact factor: 8.860

Review 9.  Pro- and anti-cancer effects of immunosuppressive agents used in organ transplantation.

Authors:  Markus Guba; Christian Graeb; Karl-Walter Jauch; Edward K Geissler
Journal:  Transplantation       Date:  2004-06-27       Impact factor: 4.939

10.  Cancers of the kidney and urinary tract in patients on dialysis for end-stage renal disease: analysis of data from the United States, Europe, and Australia and New Zealand.

Authors:  John H Stewart; Gherardo Buccianti; Lawrence Agodoa; Ryszard Gellert; Margaret R E McCredie; Albert B Lowenfels; Alex P S Disney; Robert A Wolfe; Peter Boyle; Patrick Maisonneuve
Journal:  J Am Soc Nephrol       Date:  2003-01       Impact factor: 10.121

View more
  15 in total

1.  Chronic kidney disease and risk of renal cell carcinoma: differences by race.

Authors:  Jonathan N Hofmann; Douglas A Corley; Wei K Zhao; Joanne S Colt; Brian Shuch; Wong-Ho Chow; Mark P Purdue
Journal:  Epidemiology       Date:  2015-01       Impact factor: 4.822

Review 2.  Review of renal cell carcinoma and its common subtypes in radiology.

Authors:  Gavin Low; Guan Huang; Winnie Fu; Zaahir Moloo; Safwat Girgis
Journal:  World J Radiol       Date:  2016-05-28

3.  CKD and risk of renal cell carcinoma: a causal association?

Authors:  Jonathan N Hofmann; Mark P Purdue
Journal:  J Am Soc Nephrol       Date:  2014-05-29       Impact factor: 10.121

Review 4.  Renal cell carcinoma in young patients: a review of recent literature.

Authors:  Michael Daugherty; Gennady Bratslavsky
Journal:  Curr Urol Rep       Date:  2015-02       Impact factor: 3.092

5.  Renal insufficiency is associated with an increased risk of papillary renal cell carcinoma histology.

Authors:  Solomon L Woldu; Aaron C Weinberg; Arindam RoyChoudhury; Herbert Chase; Sean D Kalloo; James M McKiernan; G Joel DeCastro
Journal:  Int Urol Nephrol       Date:  2014-07-08       Impact factor: 2.370

6.  Understanding racial disparities in renal cell carcinoma incidence: estimates of population attributable risk in two US populations.

Authors:  Catherine L Callahan; Kendra Schwartz; Douglas A Corley; Julie J Ruterbusch; Wei K Zhao; Brian Shuch; Barry I Graubard; Nathaniel Rothman; Wong-Ho Chow; Debra T Silverman; Mark P Purdue; Jonathan N Hofmann
Journal:  Cancer Causes Control       Date:  2019-11-28       Impact factor: 2.506

7.  Renal cell cancer after kidney transplantation.

Authors:  Dennis Kleine-Döpke; Matthias Oelke; Anke Schwarz; Ysabell Schwager; Frank Lehner; Jürgen Klempnauer; Harald Schrem
Journal:  Langenbecks Arch Surg       Date:  2018-07-12       Impact factor: 3.445

8.  Survival among Black and White patients with renal cell carcinoma in an equal-access health care system.

Authors:  Jie Lin; Shelia H Zahm; Craig D Shriver; Mark Purdue; Katherine A McGlynn; Kangmin Zhu
Journal:  Cancer Causes Control       Date:  2015-05-09       Impact factor: 2.506

9.  Does beer, wine or liquor consumption correlate with the risk of renal cell carcinoma? A dose-response meta-analysis of prospective cohort studies.

Authors:  Xin Xu; Yi Zhu; Xiangyi Zheng; Liping Xie
Journal:  Oncotarget       Date:  2015-05-30

Review 10.  Epidemiology and Risk Factors for Kidney Cancer.

Authors:  Ghislaine Scelo; Tricia L Larose
Journal:  J Clin Oncol       Date:  2018-10-29       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.